Price History
Feb 9, 2026 — Mar 30, 2026Investment Snapshot
- P/B of 4.73 — trading above book value
- Piotroski F-Score 8/9 — financially strong with improving fundamentals
- Loss-making — negative ROE of -13.1%
- Revenue growing at 12% annually
InnovAge Holding Corp. - Common Stock (INNV) is a Healthcare company operating in Services-Health Services, listed on the NASDAQ , with a market capitalisation of $1.1 billion . Key value metrics: P/B ratio 4.73, Piotroski F-Score 8 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
InnovAge Holding Corp. - Common Stock — Fundamental Analysis Summary
On financial health, INNV shows a strong Piotroski F-Score of 8/9, indicating improving fundamentals across profitability, leverage, and efficiency, and negative return on equity of -13.1% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.23.
StockPik's composite Value Score for INNV is 67/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
INNV reports a moderate gross margin of 20.2% (sector average: 33.5%) and a negative operating margin of -0.1%.
INNV shows revenue growing at 12% year-over-year, with earnings declining at 42%.